DNM2 and centronuclear myopathy: These data suggest that BIN1 has a novel role in regulating the GTPase activity of dynamin 2 and that dysregulation arising in CNM patients with dynamin 2 mutations is due to constitutively active GTPase activity, enhanced membrane fission, and consequential myocyte dysfunction that is tightly linked to the pathogenesis of CNM.